Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

About one in three people will develop shingles in their lifetime and nearly all adults aged 50 years and older carry the inactive virus that causes it. But the the risk of develo ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...

“By expanding eligibility for the free shingles vaccination, the Albanese Government is protecting more at-risk Australians from this debilitating virus.” Shingles is a viral infection that causes a ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...